You are here

Article info

Article menu

Download PDFPDF

Case Report
Severe immune mucositis and esophagitis in metastatic squamous carcinoma of the larynx associated with pembrolizumab

Authors

  • Fanny Zulay Acero Brand Faculty of Medicine, Department of Internal MedicineUniversité de Montréal Montréal QC Canada PubMed articlesGoogle scholar articles
  • Nicolas Suter Faculty of Medicine, Department of Internal MedicineUniversité de Montréal Montréal QC Canada PubMed articlesGoogle scholar articles
  • Jean-Philippe Adam Department of PharmacyCentre Hospitalier de l’Université de Montréal Montréal QC Canada Centre de Recherche du Centre Hospitalier de l’Université de Montréal Montréal QC Canada PubMed articlesGoogle scholar articles
  • Bernard Faulques Centre de Recherche du Centre Hospitalier de l’Université de Montréal Montréal QC Canada Department of GastroenterologyCentre Hospitalier de l’Université de Montréal Montréal QC Canada PubMed articlesGoogle scholar articles
  • Antonio Maietta Department of PathologyCentre Hospitalier de l’Université de Montréal Montréal QC Canada PubMed articlesGoogle scholar articles
  • Denis Soulières Centre de Recherche du Centre Hospitalier de l’Université de Montréal Montréal QC Canada Department of Medicine, Service of Hematology, Oncology and Blood BankCentre Hospitalier de l’Université de Montréal 1051 rue Sanguinet H2X 0C1 Montréal QC Canada PubMed articlesGoogle scholar articles
  • Normand Blais Centre de Recherche du Centre Hospitalier de l’Université de Montréal Montréal QC Canada Department of Medicine, Service of Hematology, Oncology and Blood BankCentre Hospitalier de l’Université de Montréal 1051 rue Sanguinet H2X 0C1 Montréal QC Canada PubMed articlesGoogle scholar articles
  1. ↵g normand.blais.chum{at}ssss.gouv.qc.ca
View Full Text

Citation

Acero Brand FZ, Suter N, Adam J, et al
Severe immune mucositis and esophagitis in metastatic squamous carcinoma of the larynx associated with pembrolizumab
Journal for ImmunoTherapy of Cancer 2018;6:22. doi: 10.1186/s40425-018-0332-z

Publication history

  • Received August 9, 2017
  • Accepted February 28, 2018
  • First published March 16, 2018.
Online issue publication 
February 10, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© The Author(s). Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.